Congress vs. Pharma: Trouble Ahead?
Now that the elections are over, the pharmaceutical industry is left to ponder what the new Congress has in store for it.
Pharma’s Plodding Approach to eMarketing
This article, written by health communications veteran, Harry Sweeney, is a frank assessment of the pharmaceutical industy's plodding approach to e-communication and e-marketing based on a review of a recent industry conference.
Sales Effectiveness Meets eMarketing
Steve Woodruff, Founder and Principal Consultant of Impactiviti, and John Mack team up to review eyeforpharma's Sales Effectiveness conference, which was co-located with the eCommunication & Online Marketing Conference.
Teaching New Dogs Old Tricks
An interview with Professor Jim Avery at University of Oklahoma's Gaylord College of Mass Communication about preparing graduate students for a career in health advertising.
Pharma Marketing News Vol. 5, #10
Vol. 5, No. 10: December 2006 - EXECUTIVE SUMMARY Welcome to the latest issue of Pharma Marketing News. This is the Executive Summary version....
Betting the Pharm
Pfizer's failure to launch torcetrapib will have repercussions throughout the industry on many different levels.
e-Inertia Plagues the Pharma Industry
To make sense of current estimates about pharma spending online and understand where it may be heading in the future, Pharma Marketing News recently hosted a Pharma Marketing Roundtable discussion of the issues. This article summarizes that discussion.
e-Inertia Plagues the Pharma Industry
To make sense of current estimates about pharma spending online and understand where it may be heading in the future, Pharma Marketing News recently hosted a Pharma Marketing Roundtable discussion of the issues. This article summarizes that discussion.
Pharma Online Spending
An Interview with eMarketer Senior Analyst Lisa Phillips
The Brand Marketing Mix
This article is a summary of a presentation made before a pharmaceutical brand team on marketing tactics that are viable now and in the future, how to avoid risk by balancing risk vs. impact, and what the marketing mix trends will be one to five years out.
